Logo image of SGBX

SAFE & GREEN HOLDINGS CORP (SGBX) Stock Fundamental Analysis

NASDAQ:SGBX - Nasdaq - US78418A6047 - Common Stock - Currency: USD

0.6445  -0.01 (-1.26%)

Fundamental Rating

1

Overall SGBX gets a fundamental rating of 1 out of 10. We evaluated SGBX against 49 industry peers in the Construction & Engineering industry. SGBX has a bad profitability rating. Also its financial health evaluation is rather negative. SGBX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SGBX has reported negative net income.
SGBX had a negative operating cash flow in the past year.
In the past 5 years SGBX always reported negative net income.
In the past 5 years SGBX always reported negative operating cash flow.
SGBX Yearly Net Income VS EBIT VS OCF VS FCFSGBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -303.91%, SGBX is not doing good in the industry: 97.83% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -303.91%
ROE N/A
ROIC N/A
ROA(3y)-71.69%
ROA(5y)-67.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGBX Yearly ROA, ROE, ROICSGBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 600

1.3 Margins

SGBX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGBX Yearly Profit, Operating, Gross MarginsSGBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

SGBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGBX has more shares outstanding
The number of shares outstanding for SGBX has been increased compared to 5 years ago.
The debt/assets ratio for SGBX is higher compared to a year ago.
SGBX Yearly Shares OutstandingSGBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
SGBX Yearly Total Debt VS Total AssetsSGBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

SGBX has an Altman-Z score of -18.42. This is a bad value and indicates that SGBX is not financially healthy and even has some risk of bankruptcy.
SGBX has a worse Altman-Z score (-18.42) than 95.65% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.42
ROIC/WACCN/A
WACC7.82%
SGBX Yearly LT Debt VS Equity VS FCFSGBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 0.15 indicates that SGBX may have some problems paying its short term obligations.
The Current ratio of SGBX (0.15) is worse than 97.83% of its industry peers.
SGBX has a Quick Ratio of 0.15. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
SGBX's Quick ratio of 0.10 is on the low side compared to the rest of the industry. SGBX is outperformed by 97.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.1
SGBX Yearly Current Assets VS Current LiabilitesSGBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

SGBX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.57%.
SGBX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -63.00%.
The Revenue has been growing by 15.07% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.39%
Revenue 1Y (TTM)-63%
Revenue growth 3Y23.57%
Revenue growth 5Y15.07%
Sales Q2Q%-56.17%

3.2 Future

The Earnings Per Share is expected to grow by 12.06% on average over the next years. This is quite good.
Based on estimates for the next years, SGBX will show a very strong growth in Revenue. The Revenue will grow by 68.50% on average per year.
EPS Next Y-3.1%
EPS Next 2Y12.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year103.81%
Revenue Next 2Y68.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SGBX Yearly Revenue VS EstimatesSGBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
SGBX Yearly EPS VS EstimatesSGBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SGBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SGBX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGBX Price Earnings VS Forward Price EarningsSGBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGBX Per share dataSGBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

A more expensive valuation may be justified as SGBX's earnings are expected to grow with 12.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.06%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE & GREEN HOLDINGS CORP

NASDAQ:SGBX (2/21/2025, 11:33:08 AM)

0.6445

-0.01 (-1.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-22 2024-11-22/bmo
Earnings (Next)04-14 2025-04-14/amc
Inst Owners10.42%
Inst Owner Change20.44%
Ins Owners25.88%
Ins Owner Change0%
Market Cap3.89M
Analysts82.86
Price TargetN/A
Short Float %0.4%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-87.12%
Min Revenue beat(2)-89.09%
Max Revenue beat(2)-85.14%
Revenue beat(4)0
Avg Revenue beat(4)-87.48%
Min Revenue beat(4)-92.39%
Max Revenue beat(4)-83.27%
Revenue beat(8)0
Avg Revenue beat(8)-58.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-26.62
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-2.11
FCFYN/A
OCF(TTM)-2.05
OCFYN/A
SpS1.14
BVpS-1.35
TBVpS-1.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -303.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-71.69%
ROA(5y)-67.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 98.32%
Cap/Sales 4.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.1
Altman-Z -18.42
F-Score1
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)537.79%
Cap/Depr(5y)480.39%
Cap/Sales(3y)10.3%
Cap/Sales(5y)9.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.39%
EPS Next Y-3.1%
EPS Next 2Y12.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-63%
Revenue growth 3Y23.57%
Revenue growth 5Y15.07%
Sales Q2Q%-56.17%
Revenue Next Year103.81%
Revenue Next 2Y68.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-138.94%
OCF growth 3YN/A
OCF growth 5YN/A